Abstract
Intratumoral biosynthesis of hormone steroids is thought to play a role in the pathogenesis and development of human breast cancer. There is evidence that glucocorticoids may inhibit the development and progression of breast cancer. 11β-hydroxysteroid dehydrogenase (11β-HSD) type 1 is the enzyme which converts inactive cortisone to active cortisol. In order to study the expression of 11β-HSD type 1 in breast cancer and non-cancerous breast tissue, we have developed specific antibodies to 11β-HSD type 1 and proceeded to localization of the enzyme in 84 specimens of breast carcinoma and adjacent non-malignant tissues by immnohistochemistry. The results were correlated with the expression of androgen receptor, estrogen receptor, progesterone receptor, glucocorticoid receptor and CDC47, a cell division marker, as well as the tumor stage, tumor size, nodal status and menopausal status. The expression of 11β-HSD type 1 in 64% of breast cancer specimens appeared significantly lower than that observed in normal adjacent tissues (97% of cases being positive). There was no significant correlation between 11β-HSD type 1 expression and the clinicopathological parameters studied. The decrease in 11β-HSD type 1 expression in breast cancer as compared to that observed in the adjacent normal tissues may play a role in the development and/or progression of the cancer by modifying the intratumoral levels of glucocorticoids.
Similar content being viewed by others
References
Allegra JC, Lippman ME, Thompson EB, Simon R, Barlock A, Green L, Huff KK, Do HM, Aitken SC (1979) Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. Cancer Res 39(5):1447–1454
Chapman KE, Kotelvtsev YV, Jamieson PM, Williams LJ, Mullins JJ, Seckl JR (1997) Tissue-specific modulation of glucocorticoid action by the 11 beta-hydroxysteroid dehydrogenases. Biochem Soc Trans 25(2):583–587
Darcy KM, Shoemaker SF, Lee PP, Ganis BA, Ip MM (1995) Hydrocortisone and progesterone regulation of the proliferation, morphogenesis, and functional differentiation of normal rat mammary epithelial cells in three dimensional primary culture. J Cell Physiol 163:365–379
Feigelson HS, Teras LR, Diver WR, Tang W, Patel AV, Stevens VL, Calle EE, Thun MJ, Bouzyk M (2008) Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2 and SHC1 and risk for breast cancer in the Cancer Prevention Study II. Breast Cancer Res 10(4):1–11
Gong H, Jarzynka MJ, Cole TJ, Lee JH, Wada T, Zhang B, Gao J, Song WC, DeFranco DB, Cheng SY, Xie W (2008) Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase. Cancer Res 68(18):7386–7393
Goya L, Maiyar AC, Ge Y, Firestone GL (1993) Glucocorticoids induce a G1/G0 cell cycle arrest of Con8 rat mammary tumor cells that is synchronously reversed by steroid withdrawal or addition of transforming growth factor-alpha. Mol Endocrinol 7:1121–1132
Heuson JC (1974) Hormones by administration. In: Atkins H (ed) The treatment of breast cancer. University Park Press, Baltimore, pp 140–146
Hundermark S, Büler H, Rudolf M, Weitzel HK, Ragosch V (1997) Inhibition of 11 beta-hydroxysteroid dehydrogenase activity enhances the antiproliferative effect of glucocorticoids on MCF-7 and ZR-75-1 breast cancer cells. J Endocrinol 155(1):181–180
Keith BD (2008) Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy. BMC Cancer 8:84–103
Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, Best R, Brown R, Edwards CR, Seckl JR, Mullins JJ (1997) 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci USA 94:14924–14929
Krozowski Z (1999) The 11β-hydroxysteroid dehydrogenases: functions and physiological effects. Mol Cell Endocrinol 151:121–127
Lien HC, Lu YS, Cheng AL, Chang WC, Jeng YM, Kuo YH, Huang CS, Chang KJ, Yao YT (2006) Differential expression of glucocorticoid receptor in human beast tissues and related neoplasms. J Pathol 209:317–327
Lippman M, Bolan G, Hu K (1976) The effects of glucocorticoids and progesterone on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 36:4602–4609
Lyons WR (1958) Hormonal synergism in mammary growth. Proc R Soc Lond B Biol Sci 149:303–325
Osborne CK, Monaco ME, Kahn CR, Hu K, Bonzert D, Lippman ME (1979) Direct inhibition of growth and antagonism of insulin action by glucocorticoids in human breast cancer cells in culture. Cancer Res 39:2422–2428
Pang D, Kocherginsky M, Drausz T, Kim SY, Conzen SD (2006) Dexamethasone decreases xenograft response to Paclitaxel through inhibityion of tumor cell apoptosis. Cancer Biol Ther 5(8):941–942
Pasqualini JR (2004) The selective estrogen enzyme modulators in breast cancer: a review. Biophys Acta 1654(2):123–143
Pelletier G, Luu-The V, Li S, Bujold G, Labrie F (2007) Localization and glucocorticoid regulation of 11β-hydroxysteroid dehydrogenase type 1 mRNA in the male mouse forebrain. Neuroscience 145:110–115
Sasano H, Suzuki T, Miki Y, Moriya T (2008) Intracrinology of estrogens and androgens in breast carcinoma. J Steroid Biocyhem Mol Bill 108(3–5):181–185
Song D, Liu G, Luu-The V, Zhao D, Want I, Zhang H, Xueling G, Li S, Desy L, Labrie F, Pelletier G (2006) Expression of aromatase and 17β-hydroxysteroid dehydrogease types 1, 7 and 12 in breast cancer. An immunocytochemical study. J Steroid Biochem Mol Biol 101:136–144
Steward PM, Krozowski ZS (1999) 11 beta-Hydroxysteroid dehydrogenase. Vitam Horm 57:249–324
Teulings FAG, Van Gilse HA (1977) Demonstration of glucocorticoid receptors in human mammary carcinomas. Horm Res (Basel) 8:107–116
Wang H, Want Y, Rayburn ER, Hill DL, Rinehart JJ, Zhang R (2007) Dexamethasone as a chemosensitizer for breast cancer chemotherapy: potentiaion of the antitumor activity of adriamycin, modulation of cytokine expression, and pharmacokinetics. Int J Clin Oncol 30(4):947–953
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lu, L., Zhao, G., Luu-The, V. et al. Expression of 11β-hydroxysteroid Dehydrogenase Type 1 in Breast Cancer and Adjacent Non-Malignant Tissue. An Immunocytochemical Study. Pathol. Oncol. Res. 17, 627–632 (2011). https://doi.org/10.1007/s12253-011-9361-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-011-9361-3